Tissuemed performs routine diligence work to survey surgical experience relating to use of its products. The company has supplemented this by conducting a review of numerous cases from existing customers. The results provide validation for the company’s claims that use of TissuePatch in its various forms is helping surgeons to do their job, while at the same time offering the potential to provide healthcare economic benefits, in some cases demonstrably reducing patient stay.
For the company David Mandley comments; “It has to be a desirable outcome that our product can actually improve the patient experience to the point where their stay in hospital is minimised. The patient benefit is obvious and the cost saving most welcome. Consequently our clinical work is orientated towards demonstrating not just clinical but associated economic benefit too. These reports are based on short term experience, but the suggestion is there that we can favourably influence many surgical procedures”